FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD

MLA

Kejal Kantarci, et al. “FDG PET Metabolic Signatures Distinguishing Prodromal DLB and Prodromal AD.” NeuroImage: Clinical, vol. 31, no. 102754-, Jan. 2021. EBSCOhost, https://doi.org/10.1016/j.nicl.2021.102754.

APA

Kejal Kantarci, Bradley F. Boeve, Scott A. Przybelski, Timothy G. Lesnick, Qin Chen, Julie Fields, Christopher G. Schwarz, Matthew L. Senjem, Jeffrey L. Gunte, Clifford R. Jack, Paul Min, Manoj Jain, Toji Miyagawa, Rodolfo Savica, Jonathan Graff-Radford, Hugo Botha, David T. Jones, David S. Knopman, Neill Graff-Radford, … Val J. Lowe. (2021). FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD. NeuroImage: Clinical, 31(102754-). https://doi.org/10.1016/j.nicl.2021.102754

Chicago

Kejal Kantarci, Bradley F. Boeve, Scott A. Przybelski, Timothy G. Lesnick, Qin Chen, Julie Fields, Christopher G. Schwarz, et al. 2021. “FDG PET Metabolic Signatures Distinguishing Prodromal DLB and Prodromal AD.” NeuroImage: Clinical 31 (102754-). doi:10.1016/j.nicl.2021.102754.